Palliative Care for the Patient With Mesothelioma

Seminars in Thoracic and Cardiovascular Surgery

Volumn 21, Issue 2, 2009, Pages 164-171

  Abrahm, Janet L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

chemotherapy induced peripheral neuropathy; delirium; grief and bereavement; hospice; opioid induced side effects; opioids; pain; palliative care; postthoracotomy syndrome; prognosis, advance care planning

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; CITALOPRAM; CLONIDINE; CODEINE; DEXAMETHASONE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; GABAPENTIN; HYDROMORPHONE; KETOROLAC; LAMOTRIGINE; LIDOCAINE; METHADONE; METHYLPHENIDATE; MORPHINE; NALOXONE; NORTRIPTYLINE; OPIATE; OXYCODONE; OXYMORPHONE; PAROXETINE; PHENYTOIN; PREDNISONE; PREGABALIN; SERTRALINE; TOPIRAMATE; UNINDEXED DRUG; VENLAFAXINE;

ANXIETY; ARTICLE; BEDTIME DOSAGE; BEREAVEMENT; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER PALLIATIVE THERAPY; CONSTIPATION; DEPRESSION; DISTRESS SYNDROME; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DYSPNEA; FAMILY COUNSELING; GRIEF; HUMAN; INTERCOSTAL NERVE; MALIGNANT MESOTHELIOMA; MENTAL DISEASE; MORNING DOSAGE; NAUSEA; NEUROPATHIC PAIN; PAIN; PATIENT CARE; PATIENT COUNSELING; PERIPHERAL NEUROPATHY; RELIGION; RESPIRATION DEPRESSION; SOCIAL ASPECT; THORACOTOMY; THORAX WALL;

ADAPTATION, PSYCHOLOGICAL; ADVANCE CARE PLANNING; ANALGESICS; CENTRAL NERVOUS SYSTEM AGENTS; CONSULTANTS; FAMILY RELATIONS; GRIEF; HOSPICE CARE; HUMANS; MENTAL DISORDERS; MESOTHELIOMA; PAIN; PALLIATIVE CARE; PATIENT CARE TEAM; PLEURAL NEOPLASMS; SPIRITUALITY; TREATMENT OUTCOME;

EID: 70349743983     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2009.06.006     Document Type: Article

References (19)

1. Muers M.F., Shephens R.J., Fisher P., et al. Active symptom with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): A multicentre randomized trial. Lancet 371 (2008) 1685-1694
2. Abrahm J.L. A Physician's Guide to Pain and Symptom Management in Cancer Patients. [ed 2] (2005), Johns Hopkins University Press, Baltimore, MD
3. Miaskowski C., Cleary J., Burney R., et al. Guideline for the Management of Cancer Pain in Adults and Children, APS Clinical Practice Guidelines Series. Number 3 (2005), American Pain Society, Glenview, IL
4. Smith T.J., and Coyne P.J. Implantable drug delivery systems (IDDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients. J Palliat Med 8 (2005) 736-742
5. Breivik H. Local anaesthetic blocks and epidurals. In: McMahon S.B., and Koltzenberg M. (Eds). Wall and Melzack's Textbook of Pain. (ed 5) (2006), Elsevier/Churchill Livingstone, Philadelphia, PA 507
6. Blinderman C.D., Fowler B., and Abrahm J.L. Pain management and antiemetic therapy in hematologic disorders. In: Hoffman R., Benz Jr. E.Z., Shattil S.J., et al. (Eds). Hematology, Basic Principles and Practice (2009), Elsevier/Churchill Livingstone, Philadelphia, PA 1501-1515
7. Foley K.M. Management of cancer pain. In: DeVita V.T., Hellman S., and Rosenberg S.A. (Eds). Cancer: Principles and Practice of Oncology. (ed 7) (2005), Lippincott Williams & Wilkins, Philadelphia, PA 2615
8. Davis M.P., and Walsh D. Methadone for relief of cancer pain: A review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer 9 (2001) 73-83
9. Pearson E.C., and Woosley R.L. QT prolongation and torsades de pointes among methadone users: Reports to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf 14 (2005) 747-753
10. Slatkin N., Thomas J., Lipman A.G., et al. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients. J Support Oncol 7 (2009) 39-46
11. Block S.D. Psychological issues in end-of-life care. J Palliat Med 9 (2006) 751-772
12. Cassell E. The Nature of Suffering and the Goals of Medicine. (ed 2) (2004), Oxford University Press, New York, NY
13. Block S.D., and Billings J.A. Patient requests to hasten death: Evaluation and management in terminal care. Arch Intern Med 154 (1994) 2039-2047
14. Byock I. Dying Well: The Prospect of Growth at the End of Life (1997), Riverhead Press, New York, NY
15. Balboni T.A., Vanderwerker L.C., Block S.D., et al. Religiousness and spiritual support among advanced cancer patients and associations with end-of-life treatment preferences and quality of life. J Clin Oncol 26 (2007) 555-560
16. Wright A.A., Zhang B., Ray A., et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. J Am Med Assoc 300 (2008) 1665-1673
17. Faulkner A., and Maguire P. Talking to Cancer Patients and Their Relatives (1994), Oxford Medical Publishing, Oxford
18. Abrahm J.L. Specialized care of the terminally ill. In: DeVita V.T., Lawrence T.S., and Rosenberg S.A. (Eds). DeVita, Hellman and Rosenberg's Cancer: Principles and Practice of Oncology (2008), Lippincott Williams & Wilkins, Philadelphia, PA 2830-2846
19. Casarett D., Kutner J.S., and Abrahm J. Life after death: A practical approach to grief and bereavement. Ann Intern Med 134 (2001) 208-215